Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised

Benjamin C Musall1, Refaat E Gabr1, Yanyu Yang2

  • 1Department of Diagnostic and Interventional Imaging, University of Texas McGovern Medical School, 6431 Fannin St., MSE 168, Houston, TX, 77030, USA.

Scientific Reports
|July 26, 2024
PubMed

Insights

A new deep learning tool, DAWM-Net, effectively segments diffusely abnormal white matter (DAWM) in multiple sclerosis (MS) brain MRIs using semi-supervised learning, improving upon older methods.

Area of Science:

  • Neuroimaging
  • Artificial Intelligence in Medicine
  • Medical Image Analysis

Background:

  • Diffusely abnormal white matter (DAWM) on brain MRI in multiple sclerosis (MS) patients is understudied due to a lack of automated assessment.
  • Supervised deep learning (DL) methods require extensive labeled data, posing a challenge for DAWM analysis.

Purpose of the Study:

  • To develop and validate a DL-based network (DAWM-Net) for automated segmentation of DAWM, focal lesions, and normal-appearing brain tissues.
  • To assess the performance of DAWM-Net compared to a traditional intensity thresholding method.

Main Methods:

  • A DL network (DAWM-Net) was trained using semi-supervised learning on limited labeled multiparametric MRI data.
  • DAWM-Net segmented DAWM, focal lesions, and normal-appearing brain tissues.
  • Segmentation performance was evaluated against expert consensus using Dice Similarity Coefficient (DSC) and volume correlation on an independent test set (N=25).

Main Results:

  • DAWM-Net achieved high DSC (>0.93) for normal-appearing brain tissues and (>0.81) for focal lesions.
  • DAWM-Net demonstrated improved DAWM segmentation (DSC=0.49 ± 0.12) with moderate volume correlation (ρ=0.52, p<0.01) compared to the previous method (DSC=0.26 ± 0.08, no significant correlation).

Conclusions:

  • Deep learning with semi-supervised learning is feasible for automated DAWM segmentation in MS.
  • DAWM-Net shows promise as a tool to facilitate future research into the role of DAWM in multiple sclerosis progression and pathology.

Related Concept Videos